lycorine has been researched along with s 8932 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
Aquino, TM; Araújo-Júnior, JX; Nascimento, IJDS; Santos-Júnior, PFDS; Silva-Júnior, EFD | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Jang, MS; Jeon, S; Jin, YH; Kim, HR; Kim, S; Kwon, S; Lee, J; Min, JS; Park, CM; Park, D; Park, T; Song, JH | 1 |
1 review(s) available for lycorine and s 8932
Article | Year |
---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
3 other study(ies) available for lycorine and s 8932
Article | Year |
---|---|
Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors.
Topics: Antiviral Agents; Dengue Virus; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Zika Virus | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.
Topics: Adenosine Monophosphate; Alanine; Amaryllidaceae Alkaloids; Animals; Antiviral Agents; Chlorocebus aethiops; Hydrogen Bonding; Middle East Respiratory Syndrome Coronavirus; Molecular Docking Simulation; Phenanthridines; RNA-Dependent RNA Polymerase; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Vero Cells; Viral Proteins | 2021 |